Skip to main content
U.S. Department of Energy
Office of Scientific and Technical Information

Metabolism of 1-alkyl-2-acyl-GPC in human platelets in response to stimulation by thrombin

Journal Article · · Thromb. Res.; (United States)
Washed human platelets were incubated with radioactive 1-(/sup 3/H)alkyl-2-hydroxyglycero-3-phosphocholine (lyso-PAF) at 37 degrees C. (/sup 3/H)lyso-PAF was converted by platelets into (/sup 3/H)alkylacyl-GPC which was incorporated. Incorporation of radioactivity was time dependent and reached a maximum of 57 percent in one h. This formation and incorporation of (/sup 3/H)alkylacyl-GPC was inhibited (50%) by extracellular calcium (1.3 mM). Labeled platelets were treated for 5 min with either thrombin (2.5 U/ml) or saline solution. While there was no change in the saline control, thrombin induced a reduction in the content of (/sup 3/H)alkylacyl-GPC, accompanied by an increase in (3H)lyso-PAF presumably by stimulation of phospholipase A2. There was no apparent increase in radioactivity comigrating with PAF. This was probably due to the overwhelming dilution of the radioactive alkylacyl-GPC by the endogenous nonradioactive compound (ratio-1/3200). These studies suggest that human platelets can take up lyso-PAF and acylate it to alkylacyl-GPC which is susceptible to phospholipase A2 activity.
Research Organization:
Cardeza Foundation, Philadelphia, PA
OSTI ID:
6501289
Journal Information:
Thromb. Res.; (United States), Journal Name: Thromb. Res.; (United States) Vol. 4; ISSN THBRA
Country of Publication:
United States
Language:
English